Assessing research misconduct in Iran: a perspective from Iranian medical faculty members by Shamsoddin, E. et al.
Shamsoddin et al. BMC Med Ethics           (2021) 22:74  
https://doi.org/10.1186/s12910-021-00642-2
RESEARCH
Assessing research misconduct in Iran: 
a perspective from Iranian medical faculty 
members
Erfan Shamsoddin1, Zahra Torkashvand‑Khah1, Ahmad Sofi‑Mahmudi1, Leila Janani2, Payam Kabiri3, 
Ehsan Shamsi‑Gooshki4 and Bita Mesgarpour1* 
Abstract 
Background: Research misconduct is a global concern in biomedical science. There are no comprehensive data 
regarding the perception and situation of scientific misconduct among the Iranian medical faculty members. We 
conducted a nationwide survey to assess the research misconduct among the medical faculty members in Iran.
Methods: We used the Persian version of the research misconduct questionnaire (PRMQ) on the Google Forms plat‑
form. We sent the survey link to a systematic random sample of medical faculty members in Iran (N = 4986). Descrip‑
tive analyses were performed on the individual items of the PRMQ, with frequencies and percentages for categorical 
and Likert‑type response items, and means and standard deviation (S.D.) for continuous variables. Chi‑square analysis 
was conducted to test hypotheses examining differences in the frequency of responses related to factors influencing 
misconduct. We also defined four tenure categories (TC) based on the working years of the participants as tenured 
faculty members. All the analyses were performed using R 3.6.0.
Results: The response rate was 13.8% (692 responses). Nearly 70% of the respondents agreed that their publica‑
tion output would be of higher quality if there were no publication pressure. Approximately three‑quarters (N =499, 
72.1%) of the respondents had been aware of some instances of research misconduct during the previous year 
according to their understanding of misconduct. Among the participants, 18.5% perceived the effectiveness of their 
associated organisation’s rules for reducing research misconduct to be high or very high. Pressure for tenure was iden‑
tified as the item most frequently perceived with a strong behavioural influence on engaging in research misconduct 
(80.2%).
Conclusions: This study confirms that research misconduct needs to be actively addressed among the medical fac‑
ulty members. Making policies with a focus on boosting awareness regarding the occasions of scientific misconduct 
and its management seems to be indispensable in the future in Iran.
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Background
Research misconduct has been a growing concern in 
almost every scientific field, including medical sciences 
[1]. Two of the most recognised definitions for research 
misconduct are as follows:
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1. The US Department of Health and Human Services 
Office of Research Integrity defines it as “fabrication, 
falsification, or plagiarism in proposing, perform-
ing, or reviewing research, or in reporting research 
results” [2];
2. The UK Research Integrity Office’s definition includes 
“a) fabrication, b) falsification, c) misrepresentation 
of data and/or interests and/or involvement; d) pla-
giarism; and e) failures to follow accepted procedures 
or to exercise due care in carrying out responsibilities 
for subjects and private information” [3].
While these definitions include the most severe unethi-
cal behaviours recognised as misconduct, others include 
misbehaviours such as conflict of interest and misuse 
of funds [4–6]. Considering their detrimental effects on 
individuals’ health status (e.g. patients, etc.) and exten-
sive financial costs levied upon healthcare systems, such 
wrongdoings have even more salience in medical sciences 
[7–9]. In Iran, the National Committee for Ethics in Bio-
medical Research defines research misconduct as “any 
violation of the requirements, regulations, guidances, 
guidelines, and codes to protect human participants 
in research, as approved by the Ministry of Health and 
Medical Education (MOHME) for designing, executing 
and reporting results of biomedical research, and abuse 
of intellectual property pertaining to practical and theo-
retical research findings of other parties” [10].
Even though many consider research misconduct 
resulting from inadequate training, personal circum-
stances, and individual behaviour and attitude, factors 
in the research environment (like poor supervision and 
competitive pressures) should not be overlooked [11, 
12]. Factors influencing the research misconduct occur 
in three levels: 1) research policies and strategies deter-
mined by policymakers (macro-level), 2) research devel-
opment programs run by universities and academic 
organisations (meso-level), and 3) research projects con-
ducted by individuals (micro-level) [13]. Thus, a com-
prehensive, multilevel approach is needed to reduce the 
research misconduct and its main contributing causes in 
research systems [12, 14].
Current estimates of the prevalence of research mis-
conduct differ in distinct countries. A multinational 
retrospective study on previously retracted studies in 
2013 showed that in contrast to the USA, Switzerland, 
and Germany, scientific misconduct in Iran, India, and 
Turkey had a higher ratio of publication misconduct to 
mistrusted data in the retracted studies [15]. Another 
retrospective study showed that countries with the most 
rapid growth in scientific publications (e.g. China, Malay-
sia, and Mexico) simultaneously exhibited the highest 
retraction rates [16, 17].
As concerns have been growing about the erupted cases 
of medical research misconduct globally [18], efforts have 
been exerted to measure the extent of such wrongdoings, 
whereby counteracting this issue will be more effective. 
As a part of medical research, Iranian medical research-
ers have noticeably contributed to publishing articles, 
albeit showing some cases of research misconduct in the 
previous years [19, 20]. This indicates a need for more 
information about measuring scientific misconduct in 
Iran. A few studies have scrutinised the prevalence of 
various aspects of research misconduct among Iranian 
medical researchers. A survey on the dissertation of 
undergraduate and postgraduate medical students at a 
medical school in 2015 revealed that 19% of undergradu-
ates and 25% of postgraduates had admitted committing 
misconduct [21]. Another study in academic members of 
a medical university in Iran showed that a notable pro-
portion of the respondents had engaged in at least one 
of the so-called top-ten misbehaviours introduced by 
the paper [22]. Another survey assessing the prevalence 
of publication misconduct among Iranian medical corre-
sponding authors reported guest authorship, falsification 
of study methods, and plagiarism as the three most com-
mon wrongdoings in Iran during 2009–2011 [19]. Even 
though many local studies have addressed scientific mis-
conduct in Iran, there have been no comprehensive data 
regarding the prevalence of research misconduct among 
medical faculty members in the whole country. With-
out having these figures or at least an estimate of them, 
devising effective policies to manage medical research 
misconduct (either at macro- or meso-level) in Iran will 
most probably be in vain. This study aimed to conduct 
a nationwide survey using the Persian version of the 
research misconduct questionnaire (PRMQ) among the 
faculty members of medical universities in Iran to evalu-
ate their perceptions, beliefs, practices, and experiences 
related to scientific misconduct.
Methods
Devising the PRMQ
Two questionnaires were considered as sources to be 
translated to Persian and get their psychometric charac-
teristics checked [23, 24]. Overall, 63 items were devised 
in seven subscales as follows: perception of the workplace 
environment, the prevalence of scientific misconduct, 
awareness of research misconduct, reporting research 
misconduct, beliefs about research misconduct, behav-
ioural influences, and publication pressure. The final ver-
sion of the questionnaire is accessible at https:// drive. 
google. com/ file/d/ 1nLhw ovk7q VEL7Z tw- wm0PM IzyvK 
HRCDF/ view? usp= shari ng. The validity of the Per-
sian version of the research misconduct questionnaire 
(PRMQ) was assessed qualitatively (face validity from 
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experts and pilot testing) and quantitatively (using con-
tent validity index and content validity ratio). Content 
validity indices were higher than 0.7 for all the items, 
thereby considered valid. Additionally, reliability was 
scrutinised using Cronbach’s alpha coefficient, ranging 
from 0.61 to 0.87 for all these subscales. The detailed 
steps of translating, validating, and checking the internal 
consistency of PRMQ are expounded elsewhere [25].
Participants
The PRMQ items were uploaded as an online survey on 
the Google Forms platform. After estimating the sam-
ple size, we ordered all the medical faculty members in 
Iran based on their H-index. From the beginning of this 
sorted list of faculty member (19,944 individuals), one 
of four members was randomly selected and included in 
our sample. This repeated process resulted in a system-
atic random sample of 4986 medical faculty members 
in Iran—data gathered from the Iranian Scientometric 
Information Database (ISID). This online database pro-
vides an up-to-date pool of scientometric information 
about the faculty members affiliated with the MOHME 
in Iran (isid.research.ac.ir). We sent the survey link 
twice to all of the Iranian medical scholars from March 
to November 2019. Based on their performance in edu-
cation, research, and facilities, these universities are cat-
egorised into three types by the Ministry of Health and 
Education in Iran—type one as the highest-ranked and 
type three as the lowest-ranked. Several criteria are con-
sidered for ranking these universities: contribution to sci-
ence, annual budget, research infrastructures, and human 
resource development capacity. Accordingly, type one 
universities are generally more developed and founded 
earlier than the other two types. Our participants were 
affiliated with either type one, two, or three medical uni-
versities in Iran.
Data management and analyses
We gathered all data directly from the Google Forms 
responses. There was no time limit for putting in the 
answers or any sign-in time restrictions. Participants 
were free not to answer some specific questions and to 
leave the survey at any points. Before the beginning of 
the first section of PRMQ, consent was sought and given. 
The answers were exported into Microsoft Excel (2019) 
data sheets; cleaning and sign-posting were conducted 
using the same software. Descriptive analyses were per-
formed on the individual items of PRMQ, with frequen-
cies and percentages for categorical and Likert-type 
response items (starting from one to higher integers, i.e. 
2,3,4,…), and means and standard deviation (S.D.) for 
continuous variables. We conducted a Chi-square analy-
sis to test hypotheses examining differences in frequency 
of responses. Our hypotheses could be related to factors 
influencing misconduct and reporting it or factors related 
to personally experienced publication pressure (based on 
the type of university, being aware of a research miscon-
duct occasion, or the length of serving as a tenured fac-
ulty member for each participant).
Tenure categories were defined as follows: (1) ten-
ure category one (TC1) for those who worked in tenure 
conditions for less than or equal to five years; (2) tenure 
category two (TC2) for those who worked in tenure con-
ditions for more than five years and less than or equal 
to 10 years; (3) tenure category 3 (TC3) who worked in 
tenure conditions for more than 10  years and less than 
or equal to 15 years; and (4) tenure category four (TC4) 
for those who worked in tenure conditions for more than 
15  years. An overall cumulative score was defined for 
the publication pressure subscale as the average sum of 
scores for all items in all the respondents, which could 
range between 14 and 70. This study was approved by 
an institutional ethics committee with the code number 
IR.ACECR.IBCRC.REC.1397.011 in 2018. All the analy-
ses were performed using R 3.6.0 (R Core Team, 2019), 
the “Tidyverse” package (v1.3.0, Hadley Wickham, 2019), 
and the “Questionr” package (v0.7.3, Julien Barnier, 
2020).
Results
Demographic and work setting features
Of 4986 faculty members, 692 responded (13.8% 
response rate); 393 (56.7%) were male, and 299 were 
female. The mean (S.D.) age of participants was 46.0 
(8.15) years, with a range of 28–71 years. The mean (S.D.) 
of the years of working as a tenured scholar and H-index 
of our respondents were 11.2 (9.24) and 7.1 (6.05), 
respectively. Nearly half (50.3%) of participants were affil-
iated with type-1 universities; most of them (64.4%) had 
a PhD degree, while speciality medical practitioners were 
the second most prevalent (27.1%). Table  1 depicts the 
participants’ demographic information and work setting 
features in more detail.
Almost one-third (31.6%) of the respondents prac-
tised in clinical settings, and 80.4% of them mentioned 
having served as a chair or vice-chancellor in their 
research organisations. The average period of working 
as a researcher was 7.9 (SD: 8.86). Among the involved 
researchers, 84.9% rated their understanding of rules and 
procedures related to research misconduct as high or 
very high.
Awareness of research misconduct
Responding to the question that how did anyone 
become aware of any case of research misconduct in the 
past, each individual could select more than one choice 
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from the following: observed the instance themselves, 
heard from official channels of their organisation, 
from other research coordinators, from collaborating 
investigators, from study monitors, or from institu-
tional review board. The results of this question were 
overlapping. Nearly three-quarters (N =499, 72.1%) of 
the respondents had been aware of some instances of 
research misconduct anytime before answering. We 
found no evidence for a difference in the rate of the 
awareness of misconduct among various scholars from 
differing university types or with disparate tenure expe-
rience categories (p = 0.62 and 0.48, respectively).
Perceived prevalence of scientific misconduct
The most frequent response in each category of the fac-
ulty members’ perception of the prevalence of miscon-
duct in their workplaces was “occasionally.” Disagreement 
about authorship averagely scored the highest among 
all the presented misconducts (31.2%). Plagiarism and 
falsified data were rated to be faced either occasionally 
or frequently by 66.2% and 66.5% of the participants, 
respectively. Respondents aware of misconduct were 
more likely to report higher rates of perceived prevalence 
of protocol violations related to subject enrolment (df: 3, 
p < 0.001). Figure 1 shows the perceived prevalence of sci-
entific misconduct among our participants.
Reporting of research misconduct
In answer to the question, what a typical research coordi-
nator would do if they were aware that a principal inves-
tigator (PI) or coinvestigator violated research integrity 
rules, 72.9% of scholars responded that the coordinator 
would do nothing or opts not to report the occasion. 
The figure for the same question only regarding a mem-
ber of the research team or staff member engaging in 
the wrongdoing was 69.6%. Respondents who rated the 
effectiveness of their organisational policies in tackling 
the misconduct as high or very high were more likely 
to indicate higher chances of the coordinator to report 
the misconduct (df: 3, p < 0.001). However, participants 
with awareness of misconduct were more likely to indi-
cate that a typical research coordinator would probably 
do nothing (df:3, p < 0.001). Those affiliated with type 3 
universities were more likely to rate the chance of coor-
dinators reporting the misconduct to be higher (df:6, 
p = 0.012).
Table 1 Demographic characteristics of the respondents at 
different university types
No.: Number; SD: standard deviation; IQR: inter-quartile range
Characteristic Type 1 Type 2 Type 3
Respondents’ no. 348 (50.3%) 246 (35.5%) 98 (14.2%)
Gender
Male (%) 184 (26.5%) 140 (20.3%) 69 (9.9%)
Female (%) 163 (23.5%) 107 (15.5%) 29 (4.3%)
Age (mean, SD) 47.2 (7.80) 45.2 (8.27) 43.2 (8.11)
Tenure (mean, SD) 12 (8.84) 10.6 (8.61) 9.8 (7.35)
H‑index (median, IQR) 7 (8) 4 (6) 4 (4)
Degree
Master 5 21 30
MD 117 59 14
PhD 225 167 54
Total 347 247 98
Fig. 1 The number of responses to each item in the “prevalence of scientific misconduct” section
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Perception of organisational influence on research 
misconduct
Among our participants, 78% deemed the investigator 
competitiveness high or very high in their workplaces. 
No substantiated difference was observed in pressure 
on investigators to obtain external funding among vari-
ous university types (df:6, p = 0.054). However, aca-
demics in different tenure categories rated this pressure 
differently (df:9, p = 0.008), with the highest difference 
in the mean scores between TC1 (2.7, SD:0.87) and TC4 
(2.4, SD: 0.77). Similarly, a distinction was noted among 
scholars in various tenure categories in their percep-
tion about workplace pressure to obtain tenure (df:9, 
p < 0.001). On average, respondents from TC1 (3.4, 
SD:0.718) rated this pressure more than the other ten-
ure categories.
Among the participants, 18.5% perceived the effective-
ness of their associated organisations’ rules for reduc-
ing research misconduct to be high or very high. Lower 
ratings were more likely to come from subjects in type 1 
universities than others (df:6, p = 0.0078). Furthermore, 
people aware of misconduct were more likely to rate their 
institutional policies’ effectiveness as lower compared to 
others (df:3, p < 0.001). Chances of getting caught were 
rated as low or very low by 80.6% of respondents. Based 
on university type or tenure category, no evidence of a 
difference was found in participants’ ratings of chances 
of getting caught or severity of penalties in their work-
places. Those who were aware of research misconduct 
occasions were more likely to rate the chances of getting 
caught higher than those who did not (df: 3, p < 0.001).
Behavioural influences on research misconduct
Pressure for tenure was identified as the most commonly 
perceived as having a strong behavioural influence on 
engaging in research misconduct, with a rate of 80.2% 
among Iranian medical academic scholars. Three other 
factors were also deemed to have strong behavioural 
effects on doing misconduct by more than half of our 
respondents, including the need for publication (71.1%), 
insufficient censure (punishment) for misconduct occa-
sions (60%), and need for recognition and getting reputed 
(56.5%). Figure 2 shows the behavioural influences of the 
scholars on research misconduct.
Attitudes and beliefs about scientific misconduct
Nearly three-quarters of our respondents (74.4%) were 
concerned (agreed or completely agreed) about the 
amount of misconduct in general. Additionally, most of 
our respondents (91.2%) believed (agreed or completely 
agreed) that all professional education programs should 
include information about standards of research ethics. 
More than four-fifths of those who responded (83.9%) 
did not believe (disagreed or completely disagreed) that 
dishonesty and misrepresentation of data are common in 
society and do not really hurt anybody.
Publication pressure
The overall cumulative score to all the items in the pub-
lication pressure section was 49.5. Nearly 70% of the 
respondents agreed that their publication output would 
be of higher quality if there were no publication pressure. 
Among them, 80.9% suspected that publication pressure 
Fig. 2 The number of responses to each item in the “behavioural influences on scientific misconduct” section
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leads to data manipulation in some colleagues. The schol-
ars in TC1 were more likely to believe that without pub-
lication pressure, their scientific output would have been 
of higher quality (df:12, p = 0.017). Additionally, scholars 
unaware of misconduct were more likely to find the uni-
versity’s scientific output criteria for their appointment 
and reappointment as stimulating (df:4, p = 0.001). For 
more details about the responses’ statistics in each sec-
tion of the PRMQ, please note Additional file  1, Addi-
tional file 2, Additional file 3, Additional file 4, Additional 
file 5,: Tables 1 to 5.
Discussion
After devising a reliable and valid questionnaire in Per-
sian (PRMQ), we conducted a national survey in Iran’s 
medical universities to assess the status quo about sci-
entific misconduct in faculty members. This study is the 
first interactive survey of medical faculty members (seek-
ing answers from the faculty members and not a mere 
analysis of their official databases) in Iran about their 
perceptions of research misconduct on a national scale 
to the best of our knowledge. Our study tried to reach a 
random sample of the faculty members, hence validating 
our survey sample’s representativeness among different 
university types and scholars in Iran.
However, we are uncertain whether the perception of 
academic staff about the prevalence of misconduct in 
this study accurately reflects the true prevalence of mis-
conduct in the participants’ work settings. On the other 
hand, we indirectly asked the scholars about various 
instances of misconduct (i.e. plagiarism, data fabrication, 
etc.), as if they have seen such wrongdoings in their work-
places (and not necessarily conducted by themselves). 
This could expand the coverage of misconduct identifica-
tions as one individual in each department would suffice 
to report the cases.
A recent survey of plagiarism among various demo-
graphics of researchers in Iran reported the percentage 
of plagiarism at around 30%—based on experts’ opinions 
[26]. Be that as it may, a survey by Hadji et al. in 2018 [19] 
directly assessed the prevalence of publication miscon-
duct among corresponding Iranian researchers who had 
published in Scopus-indexed journals during 2009–2011. 
Prevalence rates for plagiarism, methodology falsifica-
tion and data fabrication were reported at 4.9%, 12.65%, 
and 4.15%, respectively. However, our survey partici-
pants claimed to have frequently faced similar miscon-
ducts (plagiarism, data falsification, and data fabrication) 
with a frequency of 12.3%, 20.8%, and 12.4%, sequen-
tially. Both ours and Hadji and her colleagues’ surveys 
have represented authorship issues as the most common 
misconduct in Iran. Hadji et al. reported 18.1% of guest 
authorship in their findings, while we found that 31.2% of 
medical faculty members deemed to have frequent disa-
greements about authorship.
Pressure for obtaining tenure (p < 0.001) and external 
funding (p < 0.05) was found to be more heeded to by 
younger medical academic members (TC1) compared 
with the older scholars (TC4). Early-career scholars were 
also more likely to believe that without publication pres-
sure, their scientific output would be of higher quality 
(p < 0.05). This is previously addressed by Holtfreter et al. 
[27], who claimed that professional strains and stressors 
like publication pressure and pressure to secure external 
funds are among the most important causative factors of 
research misconduct. Medical faculty members in Iran 
are promoted based on the quantity more than the qual-
ity of their publications and also are unofficially moni-
tored by their scientometric indices. In the absence of a 
well-established qualitative promotion model in the cur-
rent academic system of Iran to assess the faculty mem-
bers, these professional strains tend to aggravate notably. 
Furthermore, the respondents perceived the “authorship 
disagreements” to have the highest number and percent-
age of “frequently seen” cases among the other miscon-
duct behaviours (N =216, 31.2%). This further proves the 
existing pressure on medical faculty members in Iran to 
reach higher academic ranks in the least time possible.
The sensitivity to research misconduct cases has signif-
icantly risen in academic working environments. Consid-
ering the recent endeavours of the National Committee 
of Ethics in Biomedicine of the Ministry of Health and 
Medical Education in Iran (including several national 
guidelines about the status and management of research 
misconduct in academic medical institutions, capacity 
building among institutional review boards on national 
and regional scales to enhance awareness of scientific 
misconduct, and national decrees about the disciplinary 
process of regulating the breaching scholars) [10, 28], the 
rising awareness of medical faculty members in Iran is 
foreseeable. Our respondents perceived the occurrence 
of misconducts to be higher as “occasional cases” rather 
than “frequent cases’ in all of the questions in the per-
ceived prevalence of scientific misconduct subscale. This 
can imply an indirect source of awareness about the mis-
conducts. Such cases have been echoed more frequently 
in the workplace due to an increased sensitivity to sci-
entific misconduct. In addition to activities mentioned 
above, ratification of “the Act for Prevention and Fighting 
against Fraud in Scientific Publications” by the Iran Par-
liament in 2017 and its executive bylaw by the Council of 
Ministers in 2019 could be known as one of the main fac-
tors that increased the sensitivity toward scientific mis-
conduct in the academic sphere.
The low perception of institutional policies’ effective-
ness against the misconducts in type 1 universities could 
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be due to higher numbers of running research projects 
and better communication settings for researchers, 
whereby one perceives the policies not to be sufficient 
to control the occasions of misconduct [28]. In other 
words, they are more likely to get aware of misconducts 
in their workplaces arbitrarily. Predictably, people aware 
of misconduct were more likely to rate this effectiveness 
as low (p < 0.001) and more likely to rank the chances of 
getting caught higher than those unaware of such occa-
sions of misconduct (p < 0.001). Moreover, participants 
aware of misconduct were more likely to indicate that 
a typical research coordinator would probably do noth-
ing when witnessing misconduct by their team members 
(p < 0.001). These are alarming perceptions that need to 
be effectively addressed before getting entrenched in the 
early- and mid-career medical researchers in Iran. It is 
imperative to hold awareness programs in faculty mem-
bers, aiming to reinforce research ethics and inform them 
about the probable consequences of such actions. This 
is in line with the findings of Mardani et  al. [13], who 
reiterated the importance of addressing organisational 
and managerial monitoring interventions (meso-level 
activities) to achieving research integrity at the individ-
ual level among Iranian medical researchers (micro-level 
activities).
Limitations
Our study’s figures should be interpreted with caution 
since the disposition of the misconduct was not speci-
fied in the questionnaire, and not all reported instances 
may have matched the same definitions. They were also 
subjective to the respondents’ understanding of each type 
of fraud [29]. As a limitation, our response rate was only 
13.8%. Nevertheless, this figure might be acceptable, con-
sidering the busy schedule of medical faculty members in 
Iran.
Using a qualitative approach to assess the research mis-
conduct in Iranian medical faculty members might have 
helped gather richer and more comprehensive findings 
and would be valuable to be conducted in the future. 
Nevertheless, the source questionnaires were meticu-
lously chosen for translation to best reflect the research 
misconduct status quo in Iran, and they both used a 
quantitative approach. Using qualitative items might fur-
ther decrease the response rate as it could have taken a 
longer period to answer open-ended questions.
Given that our survey was anonymous, the only inter-
vention to boost the response rate was a second round 
of emailing to the non-respondents. As some items in 
the publication pressure section assessed the respond-
ent’s experienced stress and considering the COVID-
19-imposed stresses on individuals in general [30], we did 
not do a third round of emailing during the COVID-19 
pandemic. Another limitation might be that the defini-
tion of misconduct used in Iran is broader than that used 
in other countries or other surveys, making it difficult to 
make comparisons.
Conclusions
While addressing the limitation of our study, a significant 
proportion of medical faculty members in Iran had been 
aware of some research misconduct cases in the past. 
Granted, there is a viable need to continually educate 
medical researchers about the repercussions of scien-
tific misconduct, yet more adaptive approaches to miti-
gate professional strains on early-career researchers are 
advisable.
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